<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chia R</submitter><funding>Intramural NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Wellcome Trust</funding><pagination>2142-2156.e5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11223971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(13)</volume><pubmed_abstract>Multiple system atrophy (MSA) is an adult-onset, sporadic synucleinopathy characterized by parkinsonism, cerebellar ataxia, and dysautonomia. The genetic architecture of MSA is poorly understood, and treatments are limited to supportive measures. Here, we performed a comprehensive analysis of whole genome sequence data from 888 European-ancestry MSA cases and 7,128 controls to systematically investigate the genetic underpinnings of this understudied neurodegenerative disease. We identified four significantly associated risk loci using a genome-wide association study approach. Transcriptome-wide association analyses prioritized USP38-DT, KCTD7, and lnc-KCTD7-2 as novel susceptibility genes for MSA within these loci, and single-nucleus RNA sequence analysis found that the associated variants</pubmed_abstract><journal>Neuron</journal><pubmed_title>Genome sequence analyses identify novel risk loci for multiple system atrophy.</pubmed_title><pmcid>PMC11223971</pmcid><funding_grant_id>U01 AG061356</funding_grant_id><funding_grant_id>R01 HL120393</funding_grant_id><funding_grant_id>R01 HL117626</funding_grant_id><funding_grant_id>P30 AG072980</funding_grant_id><funding_grant_id>P30 AG066507</funding_grant_id><funding_grant_id>U24 NS072026</funding_grant_id><funding_grant_id>U01 HL120393</funding_grant_id><funding_grant_id>R01 NS109209</funding_grant_id><funding_grant_id>P30 AG072977</funding_grant_id><funding_grant_id>ZIA NS003154</funding_grant_id><funding_grant_id>P30 AG019610</funding_grant_id><funding_grant_id>ZIA AG000935</funding_grant_id><funding_grant_id>P50 NS038377</funding_grant_id><funding_grant_id>U19 AG063911</funding_grant_id><pubmed_authors>Krismer F</pubmed_authors><pubmed_authors>Foubert-Samier A</pubmed_authors><pubmed_authors>Sidoroff V</pubmed_authors><pubmed_authors>Proukakis C</pubmed_authors><pubmed_authors>Chelban V</pubmed_authors><pubmed_authors>Floris G</pubmed_authors><pubmed_authors>Ray A</pubmed_authors><pubmed_authors>Kwei KT</pubmed_authors><pubmed_authors>Hardy JA</pubmed_authors><pubmed_authors>Canosa A</pubmed_authors><pubmed_authors>Masliah E</pubmed_authors><pubmed_authors>Shah Z</pubmed_authors><pubmed_authors>Barone P</pubmed_authors><pubmed_authors>Topol E</pubmed_authors><pubmed_authors>Dalgard CL</pubmed_authors><pubmed_authors>Sait S</pubmed_authors><pubmed_authors>Marin-Lahoz J</pubmed_authors><pubmed_authors>Karra R</pubmed_authors><pubmed_authors>Pavy-Le Traon A</pubmed_authors><pubmed_authors>Reynolds RH</pubmed_authors><pubmed_authors>Singer W</pubmed_authors><pubmed_authors>Cheshire WP</pubmed_authors><pubmed_authors>Clarimon J</pubmed_authors><pubmed_authors>Russillo MC</pubmed_authors><pubmed_authors>Perinan MT</pubmed_authors><pubmed_authors>Morris HR</pubmed_authors><pubmed_authors>Kim C</pubmed_authors><pubmed_authors>Bohannan RC</pubmed_authors><pubmed_authors>Iba M</pubmed_authors><pubmed_authors>Torres S</pubmed_authors><pubmed_authors>Kobylecki C</pubmed_authors><pubmed_authors>Sanchez-Juan P</pubmed_authors><pubmed_authors>Rubio I</pubmed_authors><pubmed_authors>Zimprich A</pubmed_authors><pubmed_authors>Hu MT</pubmed_authors><pubmed_authors>Fanciulli A</pubmed_authors><pubmed_authors>Low PA</pubmed_authors><pubmed_authors>Pellecchia MT</pubmed_authors><pubmed_authors>Albert MS</pubmed_authors><pubmed_authors>Kaufmann H</pubmed_authors><pubmed_authors>Gibbs JR</pubmed_authors><pubmed_authors>Fujita M</pubmed_authors><pubmed_authors>Meissner WG</pubmed_authors><pubmed_authors>Rascol O</pubmed_authors><pubmed_authors>Chia R</pubmed_authors><pubmed_authors>Traynor BJ</pubmed_authors><pubmed_authors>Diez-Fairen M</pubmed_authors><pubmed_authors>Bennett DA</pubmed_authors><pubmed_authors>Kaivola K</pubmed_authors><pubmed_authors>Beach TG</pubmed_authors><pubmed_authors>Pantelyat A</pubmed_authors><pubmed_authors>Seppi K</pubmed_authors><pubmed_authors>Scholz SW</pubmed_authors><pubmed_authors>Dickson DW</pubmed_authors><pubmed_authors>Tison F</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Mir P</pubmed_authors><pubmed_authors>Wszolek ZK</pubmed_authors><pubmed_authors>Parkkinen L</pubmed_authors><pubmed_authors>Litvan I</pubmed_authors><pubmed_authors>Goh YY</pubmed_authors><pubmed_authors>Walton RL</pubmed_authors><pubmed_authors>Wenning GK</pubmed_authors><pubmed_authors>Rollinson S</pubmed_authors><pubmed_authors>Garland E</pubmed_authors><pubmed_authors>Norcliffe-Kaufmann L</pubmed_authors><pubmed_authors>Leys F</pubmed_authors><pubmed_authors>Lage C</pubmed_authors><pubmed_authors>Houlden H</pubmed_authors><pubmed_authors>Khurana V</pubmed_authors><pubmed_authors>Ndayisaba A</pubmed_authors><pubmed_authors>Flanagan ME</pubmed_authors><pubmed_authors>Ruffo P</pubmed_authors><pubmed_authors>Akcimen F</pubmed_authors><pubmed_authors>Stefanova N</pubmed_authors><pubmed_authors>Calvo A</pubmed_authors><pubmed_authors>Palma JA</pubmed_authors><pubmed_authors>Biaggioni I</pubmed_authors><pubmed_authors>Infante J</pubmed_authors><pubmed_authors>Mao Q</pubmed_authors><pubmed_authors>Ryten M</pubmed_authors><pubmed_authors>Rosenthal LS</pubmed_authors><pubmed_authors>Ding J</pubmed_authors><pubmed_authors>Alcalay RN</pubmed_authors><pubmed_authors>Menon V</pubmed_authors><pubmed_authors>Dawson TM</pubmed_authors><pubmed_authors>Pletnikova O</pubmed_authors><pubmed_authors>Troncoso JC</pubmed_authors><pubmed_authors>Kulisevsky J</pubmed_authors><pubmed_authors>Duerr S</pubmed_authors><pubmed_authors>Saxon JA</pubmed_authors><pubmed_authors>Pirker W</pubmed_authors><pubmed_authors>De Jager PL</pubmed_authors><pubmed_authors>Alvarez I</pubmed_authors><pubmed_authors>Castellani RJ</pubmed_authors><pubmed_authors>Saez-Atienzar S</pubmed_authors><pubmed_authors>Reho P</pubmed_authors><pubmed_authors>Ross OA</pubmed_authors><pubmed_authors>Pastor P</pubmed_authors><pubmed_authors>Serrano GE</pubmed_authors><pubmed_authors>Mora G</pubmed_authors><pubmed_authors>Chio A</pubmed_authors><pubmed_authors>Moore A</pubmed_authors><pubmed_authors>Lubbe SJ</pubmed_authors><pubmed_authors>Albani D</pubmed_authors><pubmed_authors>Torkamani A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome sequence analyses identify novel risk loci for multiple system atrophy.</name><description>Multiple system atrophy (MSA) is an adult-onset, sporadic synucleinopathy characterized by parkinsonism, cerebellar ataxia, and dysautonomia. The genetic architecture of MSA is poorly understood, and treatments are limited to supportive measures. Here, we performed a comprehensive analysis of whole genome sequence data from 888 European-ancestry MSA cases and 7,128 controls to systematically investigate the genetic underpinnings of this understudied neurodegenerative disease. We identified four significantly associated risk loci using a genome-wide association study approach. Transcriptome-wide association analyses prioritized USP38-DT, KCTD7, and lnc-KCTD7-2 as novel susceptibility genes for MSA within these loci, and single-nucleus RNA sequence analysis found that the associated variants</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-02T17:48:43.027Z</modification><creation>2026-05-27T03:07:51.616Z</creation></dates><accession>S-EPMC11223971</accession><cross_references><pubmed>38701790</pubmed><doi>10.1016/j.neuron.2024.04.002</doi></cross_references></HashMap>